drug

pevifoscorvir sodium

1 story · latest Aug 6, 2026

Status: Investigational
Code: ALG-000184
Trials: 3 registered trials in coverage

Relationships

Developed by Aligos Therapeutics

Timeline

Aligos reports Q2 2026 results, pevifoscorvir sodium enrollment complete

Aug 6Quarterly updateAligos Therapeutics pevifoscorvir sodium

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.